ClinConnect ClinConnect Logo
Search / Trial NCT00669266

Adrenal Tumors - Pathogenesis and Therapy

Launched by UNIVERSITY OF WUERZBURG · Apr 29, 2008

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Adrenal Tumors - Pathogenesis and Therapy," is studying adrenal tumors, which are growths that occur in the adrenal glands located on top of the kidneys. These tumors can lead to serious conditions such as Cushing syndrome, Conn syndrome, and pheochromocytoma. The researchers want to better understand how these tumors develop and to evaluate different treatment options for a specific type of adrenal tumor called adrenocortical carcinoma. This study is currently looking for participants of all ages (from infants to adults) who have been diagnosed with an adrenal tumor through imaging tests.

If you or a loved one has been diagnosed with an adrenal tumor, you may be eligible to participate in this trial. The main requirement is that there must be a confirmed adrenal tumor detected by imaging. Participants in this study will have the opportunity to contribute to important research that could improve treatment options for adrenal tumors in the future. Being part of this trial may also provide access to new therapies and close monitoring by healthcare professionals. If you're interested, it's a good idea to talk to your doctor about the details and what participating would involve.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • adrenal tumor detected by imaging
  • Exclusion Criteria:

About University Of Wuerzburg

The University of Würzburg, a prestigious institution located in Bavaria, Germany, is renowned for its commitment to advancing medical research and education. With a rich history dating back to 1402, the university is home to a diverse range of interdisciplinary research initiatives, particularly in the fields of medicine, life sciences, and pharmacology. As a clinical trial sponsor, the University of Würzburg is dedicated to conducting innovative research that aims to improve patient outcomes and contribute to the global medical community. The institution emphasizes ethical practices, rigorous scientific methodologies, and collaboration with various stakeholders to ensure the integrity and success of its clinical trials.

Locations

Wuerzburg, , Germany

Patients applied

0 patients applied

Trial Officials

Martin Fassnacht, MD

Principal Investigator

U of Wuerzburg

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials